Treatment costs of early-stage lung cancers detected by low-dose computed tomography screening

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 1, 2015, Pages 207-208

  Verma, Vivek ^a   Zhen, Weining ^a  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURGERY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; EARLY CANCER; HEALTH CARE COST; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; LOBECTOMY; LUNG CANCER; NON SMALL CELL LUNG CANCER; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SMOKING; CARCINOMA, NON-SMALL-CELL LUNG; COMPUTER ASSISTED RADIOTHERAPY; ECONOMICS; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; RADIOGRAPHY; RADIOSURGERY; SURGERY;

CARCINOMA, NON-SMALL-CELL LUNG; HEALTH CARE COSTS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIATION DOSAGE; RADIOSURGERY; RADIOTHERAPY, CONFORMAL; SURGICAL PROCEDURES, OPERATIVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84939442802     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.03.036     Document Type: Article

References (6)

1. National Lung Screening Trial Research Team D.R. Aberle, A.M. Adams, C.D. Berg, and et al. Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
2. National Comprehensive Cancer Network. Non-small cell lung cancer (version 4.2015). www.nccn.org/professionals/physician-gls/pdf/nscl.pdf. Accessed February 7, 2015.
3. D.J. Sher, J.O. Wee, and R.S. Punglia Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 767 774
4. A. Shah, S.M. Hahn, R.L. Stetson, and et al. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer Cancer 119 2013 3123 3132
5. T.B. Lanni Jr., I.S. Grills, L.L. Kestin, and et al. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer Am J Clin Oncol 34 2011 494 498
6. V. Puri, T.D. Crabtree, S. Kymes, and et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: A decision analysis J Thorac Cardiovasc Surg 143 2012 428 436